General Information of Drug Inactive Ingredient (DIG) (ID: E00398)

DIG Name
Cholesteryl stearate
Synonyms
Cholesteryl stearate; Cholesterol stearate; 35602-69-8; Cholesteryl octadecanoate; Cholestryl stearate; 18:0 Cholesteryl ester; CE(18:0); Cholest-5-en-3-beta-yl stearate; UNII-I1Q82N9DYQ; cholest-5-en-3beta-yl octadecanoate; 5-Cholesten-3.beta.-ol stearate; I1Q82N9DYQ; cholest-5-en-3beta-yl stearate; Cholest-5-en-3-ol (3.beta.)-, octadecanoate; 3beta-octadecanoyloxycholest-5-ene; MFCD00003639; [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] octadecanoate; Cholesterol, stearate; 5-Cholesten-3beta-yl octadecanoate; Cholest-5-en-3-ol-, octadecanoate; EINECS 252-637-0; NSC 59693; Cholestryl stearic acid; Cholesterol stearic acid; bmse000849; Cholesteryl stearate, 96%; Cholesteryl octadecanoic acid; Cholesterol, stearate (8CI); Cholest-5-en-3b-yl stearate; SCHEMBL126915; Stearic Acid Cholesterol Ester; Cholest-5-en-3-b-yl stearate; 3b-Octadecanoyloxycholest-5-ene; CHEBI:82750; Cholest-5-en-3b-yl octadecanoate; Cholest-5-en-3b-yl stearic acid; DTXSID101018693; Cholest-5-en-3-b-yl stearic acid; Cholest-5-en-3-b-yl octadecanoate; NSC59693; Cholest-5-en-3beta-yl stearic acid; ANW-28248; LMST01020007; NSC-59693; ZINC40165274; 3.beta.-Octadecanoyloxycholest-5-ene; Cholest-5-en-3-beta-yl stearic acid; Cholest-5-en-3-beta-yl octadecanoate; Cholest-5-en-3b-yl octadecanoic acid; Cholest-5-en-3-b-yl octadecanoic acid; Cholest-5-en-3beta-yl octadecanoic acid; (3beta)-cholest-5-en-3-yl octadecanoate; Cholest-5-en-3-beta-yl octadecanoic acid; Cholest-5-en-3-ol (3beta)-, octadecanoate (9CI); W-106661; Q27156278; UNII-137SL7IL0Y component XHRPOTDGOASDJS-XNTGVSEISA-N; UNII-DFP79OD7KP component XHRPOTDGOASDJS-XNTGVSEISA-N; UNII-T2EIE22I4V component XHRPOTDGOASDJS-XNTGVSEISA-N
DIG Function
Emollient; Emulsifying agent
Formula
C45H80O2
Canonical SMILES
CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C
InChI
1S/C45H80O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h26,35-36,38-42H,7-25,27-34H2,1-6H3/t36-,38+,39+,40-,41+,42+,44+,45-/m1/s1
InChIKey
XHRPOTDGOASDJS-XNTGVSEISA-N
Physicochemical Properties Molecular Weight 653.1 Topological Polar Surface Area 26.3
XlogP 17.5 Complexity 934
Heavy Atom Count 47 Rotatable Bond Count 23
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2

Full List of Drug(s) Co-administrated with This DIG

1 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Aspirin DM672AH Myocardial infarction [BA41-BA43] Aspirin 325 mg tablet F01607
------------------